Answers are grounded in this paper and cite their sources.
The MRI contrast agents (CAs) have been routinely used for detecting tumors at early stages. Currently, the most used CAs in MRI are gadolinium (Gd 3+ ) complexes. However, these CAs can be toxic to the body. Thus, this work proposes Ni 2+ complexes ([Ni(ACAC) 2 (H 2 O) 2 ], [Ni(TEA)] 2+ ) as promising CAs. For the theoretical prediction, molecular dynamics simulations were carried out and the conformations were selected by the optimal wavelet signal compression algorithm method. The T 1 and T 2 values were obtained directly by means of the spectral density. Our findings showed that the Ni 2+ complexes can be promising CAs in MRI.
No takes yet. Share an insight, caveat, or question.
Gonçalves et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: